Matches in Wikidata for { <http://www.wikidata.org/entity/Q91361625> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q91361625 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91361625 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91361625 description "scientific article published on 01 November 2019" @default.
- Q91361625 description "wetenschappelijk artikel" @default.
- Q91361625 description "наукова стаття, опублікована 1 листопада 2019" @default.
- Q91361625 name "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 name "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 type Item @default.
- Q91361625 label "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 label "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 prefLabel "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 prefLabel "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 P1433 Q91361625-DC68EE70-22D2-40D0-8030-2DD14A2EE7A8 @default.
- Q91361625 P1476 Q91361625-AA0B3C94-8722-4363-A23C-E7B725EF4005 @default.
- Q91361625 P2093 Q91361625-6C9685FF-AC85-40B1-9AD1-832A84FE92E4 @default.
- Q91361625 P2093 Q91361625-931B3257-C08F-4560-A2E9-DA3FAB72EBC2 @default.
- Q91361625 P304 Q91361625-5C6D87EA-9C09-4518-A38D-49D4D6E899F5 @default.
- Q91361625 P31 Q91361625-39C9B67F-F443-443D-A6FF-8D01427553C3 @default.
- Q91361625 P433 Q91361625-C0EF3C24-DEDB-4B3C-82A6-BDF5C9BE3B28 @default.
- Q91361625 P478 Q91361625-FFAFD20D-4867-4109-9621-CD6B60C57A2A @default.
- Q91361625 P577 Q91361625-AF207953-BC74-45C1-8050-189CD0A730BD @default.
- Q91361625 P698 Q91361625-030012AE-B445-437D-8793-2D73F9B466CD @default.
- Q91361625 P698 31748471 @default.
- Q91361625 P1433 Q27709096 @default.
- Q91361625 P1476 "[Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]" @default.
- Q91361625 P2093 "Hiroshi Kawamoto" @default.
- Q91361625 P2093 "Seiji Nagano" @default.
- Q91361625 P304 "1677-1682" @default.
- Q91361625 P31 Q13442814 @default.
- Q91361625 P433 "11" @default.
- Q91361625 P478 "46" @default.
- Q91361625 P577 "2019-11-01T00:00:00Z" @default.
- Q91361625 P698 "31748471" @default.